Articles by Cecilia Brown
The study was conducted because it was “uncertain whether a fractionated schedule provides additional benefit."
Researchers analyzed prognostic impact of NPM1 MRD in a real-world cohort of patients with NPM1-mutated AML.
The primary endpoints were short-term event-free survival and overall survival in the intention-to-treat population.
Researchers retrospectively analyzed treatment outcomes of 69 patients with relapsed or refractory CRLF2-rearranged B-ALL.
Low hypodiploidy “defines a rare subtype” of B-cell ALL with a “dismal outcome.”
The retrospective, observational study included adults who received their first allogeneic HSCT during their first remission.
Dr. Coombs discusses her journey into oncology, what it’s like to broach the lymphoid and myeloid worlds, and a unique ...
The proof-of-concept study showed that noninvasive hemoglobin measurement is “feasible,” but there were several ...
One aim is to evaluate the efficacy of oral decitabine/cedazuridine and magrolimab in intermediate to HR MDS.
All patients included in the study required treatment and had not previously received psychiatric treatment.
The study included patients with relapsed or refractory B-cell malignancies who were in the phase I/II BRUIN trial.
The researchers investigated if iso-cel in patients with relapsed or refractory CLL is a cost-efficient option.
Patients with MPNs faced higher direct and indirect costs and were significantly more likely to take disability leave.
Researchers presented data from the randomized withdrawal phase of the study at the SOHO Annual Meeting.
Researchers sought to differentiate the mechanism of action of luspatercept from epoetin alfa.
The patient cohort had median OS of 27 months and a five-year OS of 24.5%.
The award recognizes a SOHO member who has significantly contributed to the advancement of blood cancer care and research.
Dr. Brown shares what CLL news and session she's watching at the Eleventh Annual Meeting of SOHO.
Multiple posters received awards from the Society during a ceremony held at the annual meeting.
SOHO President Jennifer Brown, MD, PhD, talks about why she chose personalized medicine as this year's theme.
630 Madison Ave.
Manalapan, NJ 07726
© 2023 Mashup Media, LLC. All rights reserved.